NY-BREGAL-SAGEMOUNT
Bregal Sagemount (“Sagemount”), a leading growth-focused private equity firm, today announced a strategic growth investment in Enhesa (the “Company”), a leading provider of regulatory and sustainability intelligence worldwide. As part of the transaction, Sagemount will acquire ICG’s minority stake in Enhesa, with existing investor CGE Partners (“CGE”) retaining its majority stake in the Company. Financial terms of the transaction were not disclosed.
With its global headquarters in Brussels, Belgium and U.S. headquarters in Arlington, VA, Enhesa empowers multinational corporations worldwide to help create a more sustainable future by positively impacting the environment and ensuring the health and safety of their employees and customers. Bringing together some of the world’s most comprehensive data sets, AI-powered analytics, and renowned subject matter experts in the areas of global operations, product, and chemicals management compliance and sustainability, Enhesa provides actionable compliance intelligence in over 40 languages across more than 300 jurisdictions, supported by a team of over 100 in-house legal experts. Navigating the fast-changing regulatory landscape, Enhesa helps corporations meet their compliance and sustainability needs with confidence, now and in the future.
“We are thrilled to be partnering with Sagemount as we enter our next stage of growth,” said Peter Schramme, CEO of Enhesa. “With their and CGE’s support and deep industry expertise, we believe we are well-positioned to further invest in our current offerings as well as accelerate new content coverage, use cases, and customer verticals.”
“We see tremendous growth ahead for Enhesa as a result of the Company’s strong product-market fit and tangible customer ROI,” said Pavan Tripathi, Partner at Sagemount. “Enhesa has an impressive track record of consistently retaining and growing its customer relationships as well as expanding new content offerings and jurisdictional coverage through both organic and inorganic growth initiatives. We are excited to be working with Peter, the Enhesa team, and CGE.”
David Greenbaum, Vice President at Sagemount, added, “For enterprises that operate, manufacture, and sell globally, Enhesa is by far the leading third-party content provider, allowing companies to monitor relevant Environmental, Health, & Safety (“EHS”) and other regulations across the enterprise significantly faster and more accurately than internal teams or disparate, regional third-party content providers.”
"We have enjoyed a highly successful partnership with Enhesa since acquiring the Company in 2020. Under CGE’s ownership to date, Enhesa has meaningfully scaled its business, expanded its industry-leading regulatory compliance content set from EHS to also include Product Compliance and Sustainability Intelligence, and completed five strategic add-on acquisitions," CGE commented. "We look forward to continuing to support Enhesa in its next chapter of growth alongside Sagemount."
Sagemount’s investment was led by Pavan Tripathi, Sandeep Swaminathan, David Greenbaum, Harrison Boyajian, and Stephanie Li. Sagemount was advised by Raymond James and Goodwin Procter. Enhesa and CGE were advised by Houlihan Lokey and Travers Smith.
About Enhesa
Enhesa is the leading provider of regulatory and sustainability intelligence worldwide. Headquartered in Brussels, with offices in Washington, DC, Williamsport, PA, Toronto, the United Kingdom, Tokyo, Shanghai, and Portugal, Enhesa empowers multinational corporations worldwide to create a more sustainable future by positively impacting the environment and ensuring the health and safety of their employees and customers. Bringing together some of the world’s most comprehensive data sets, AI-powered analytics, and renowned subject matter experts in the areas of global operations, product, and chemicals management compliance and sustainability, Enhesa provides actionable compliance intelligence in over 40 languages across more than 300 jurisdictions. Navigating the fast-changing regulatory landscape, Enhesa helps corporations meet their compliance and sustainability needs with confidence, now and in the future. For more information on Enhesa, go to the firm's website at www.enhesa.com.
About Sagemount
Bregal Sagemount is a leading growth-focused private capital firm with more than $6.0 billion of capital raised. The firm provides flexible capital and strategic assistance to market-leading companies in high-growth sectors across a wide variety of transaction situations. Bregal Sagemount has invested in over 70 companies in a variety of sectors, including software, information / data services, financial technology & specialty finance, digital infrastructure, healthcare IT, and business & consumer services. The firm has offices in New York, Palo Alto, and Dallas. For more information, visit the Sagemount website: www.sagemount.com or follow us on LinkedIn.
About CGE
CGE Partners is a European mid-market investment fund. CGE invests in tech-enabled businesses facilitating the transition to a more digital, renewable, secure, and compliant future, providing capital and expertise to accelerate expansion in global markets. For more information, visit the CGE website: https://cge-partners.com/.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230110005348/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Nexo Becomes First-Ever Title Partner of the U.S. ATP 500 Dallas Open in Multi-Year Deal13.1.2026 16:30:00 CET | Press release
The agreement builds on Nexo’s long-term approach to partnerships with established global sports institutions. Nexo, the digital assets wealth platform, has been named the U.S. ATP 500 Dallas Open’s first-ever Title Partner under a multi-year agreement beginning in 2026, as the company advances its long-term brand strategy through leading global sports properties. The partnership was unveiled in Dallas alongside the debut of the Nexo Dallas Open brand and the resurfacing of two public tennis courts in North Texas. As one of only two ATP 500 tournaments in the U.S. and the country’s sole indoor ATP Tour championship, the Dallas Open places Nexo among a limited group of ATP 500 title partners. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260113901822/en/ The Nexo Dallas Open “This partnership with Nexo represents a transformative milestone for the Dallas Open,” said Tournament Director Peter Lebedevs. “Securing a title spons
Blue Matter Establishes New Capabilities in Biopharma Research & Development Led by Partner, Tara Austraat-Churik13.1.2026 15:01:00 CET | Press release
Blue Matter is pleased to announce that it has established a practice area dedicated to serving clients in biopharmaceutical Research & Development (R&D). The practice is led by Tara Austraat-Churik, a Partner who joined the firm in September 2025. Tara Austraat-Churik has been serving life science clients for more than 20 years. Her areas of expertise include strategy development and implementation, operating model and organizational design, and process optimization in R&D and Medical Affairs. Prior to joining Blue Matter, she served as Managing Director in R&D, Health, Science, and Wellness at EY. She has a robust background in consulting, which also includes roles at Booz Allen Hamilton, Navitas, WPP, and IBM. She holds a BA and MA from the University of Notre Dame and an MSc in Translational Medicine from the University of Edinburgh. The R&D practice, according to Austraat-Churik, exists to help biopharma companies simplify and accelerate the pathway to market. She adds, “R&D organ
Wasabi Raises $70M in New Equity to Power the Next Era of Data Infrastructure13.1.2026 15:00:00 CET | Press release
At a $1.8 billion valuation, backed by L2 Point and Pure Storage, the company scales AI-first cloud storage to meet the explosive demands of modern data Wasabi Technologies, the Hot Cloud Storage company, today announced a $70 million equity funding round led by L2 Point Management with participation from Pure Storage and existing investors including Fidelity Management & Research Company. The new round values Wasabi at $1.8 billion and brings the company’s total funding to over $600 million. The capital will be used to accelerate Wasabi’s expansion into AI infrastructure, broaden its global footprint, and enhance its product portfolio to meet the growing data demands of enterprises and AI developers worldwide. “We’re ushering in the next generation of cloud storage, powering data-intensive workloads like generative AI and autonomous systems,” said David Friend, co-founder and CEO of Wasabi Technologies. “This funding underscores Wasabi’s strong market position and continued growth as
HumanX Amsterdam Reveals First 100 Speakers, Bringing Global AI Powerhouses to Europe13.1.2026 14:00:00 CET | Press release
Anton Osika (Lovable), May Habib (Writer), Jan Oberhauser (n8n) & Eléonore Crespo (Pigment) headline a diverse lineup spanning AI innovation and enterprise adoption HumanX, the global AI summit for executives and innovators, today unveiled its first 100 speakers and opened registration for HumanX Amsterdam, taking place 22–24 September 2026 at The RAI. Built by the team behind Money20/20, Shoptalk, and HLTH, HumanX Amsterdam brings the proven formula of its #1 U.S. flagship event and ecosystem gathering to Europe. The event convenes over 2,500 senior leaders focused on moving beyond the hype to drive practical, responsible AI implementation across industries. Speakers Leading the Conversation The first 100 speakers include AI company founders such as Anton Osika (Lovable), Jan Oberhauser (n8n), May Habib (Writer), Arvind Jain (Glean), and Jarek Kutylowski (DeepL), alongside executives scaling AI in the enterprise, including Clay Bavor (Sierra), Des Traynor (Intercom), and Eléonore Cres
GARDP and Debiopharm Partner to Advance Development of Novel Gonorrhea Drug13.1.2026 14:00:00 CET | Press release
The GARDP Foundation (known as GARDP) and the privately-owned, global biopharmaceutical company Debiopharm today announced that they have entered into a collaboration and license agreement to pursue the development of Debio1453, a novel, first-in-class antibiotic targeting Neisseria gonorrhoeae. With 82 million new cases each year, and the continued spread of multidrug-resistant N. gonorrhoeae strains, gonorrhea represents a global health crisis. This new partnership will help ensure that gonorrhea continues to be a treatable disease and will alleviate the risk of the emergence of future resistance, by ensuring that the antibiotic pipeline continues to be replenished. Gonorrhea caused by N. gonorrhoeae is currently in danger of becoming untreatable because of antimicrobial resistance (AMR). Having developed resistance to almost all antibiotics used to treat it, only one last recommended treatment, ceftriaxone, remains effective, and now we are seeing a growing number of cases that are
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom